HLA-G and neoplasm: On the basis of these observations, we discuss future possible therapeutic strategies based on the combination of (i) blocking antibodies against HLA-G or its receptors and (ii) blocking antibodies specific for other IC molecules, with the aim of fully restoring anti-tumor immune response.